Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 4/20 | 0.38 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708539 | 0.93 | AGTR1 (0.40) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9707991 | 0.92 | AGTR1 (0.38) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9708060 | 0.91 | MAPK1 (0.41) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9708659 | 0.90 | AGTR1 (0.39) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9708118 | 0.90 | PDE5A (0.39) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9707734 | 0.90 | AGTR1 (0.37) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9707509 | 0.89 | AGTR1 (0.42) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9707743 | 0.89 | KMT2A (0.42) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9708348 | 0.89 | ADORA3 (0.41) | AGTR1AGTR2KMT2APOLBMAPK1 | |
| SCHEMBL9707976 | 0.89 | PDE5A (0.38) | AGTR1AGTR2KMT2APOLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |